Steve Elms, Director, Ten Percent Owner at Loxo Oncology, holds 2.19M shares in ADMA Biologics (Ticker: ADMA), holds 2.74M shares in Zosano Pharma (Ticker: ZSANQ), holds 3.16M shares in Marker Therapeutics (Ticker: MRKR). Most recently, Steve Elms Sold ― shares of ADMA Biologics on Mar 19, 2024 for an estimated value of 2.80M.